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Abstract
Background: Endotoxin induced chorioamnionitis increases IL-1 and provokes an inflammatory response in the fetal ileum
that interferes with intestinal maturation. In the present study, we tested in an ovine chorioamnionitis model whether IL-1 is
a major cytokine driving the inflammatory response in the fetal ileum.
Method: Sheep bearing singleton fetuses received a single intraamniotic injection of recombinant ovine IL-1a at 7, 3 or 1 d
before caesarian delivery at 125 days gestational age (term=150 days).
Results: 3 and 7 d after IL-1a administration, intestinal mRNA levels for IL-4, IL-10, IFN-c and TNF-a were strongly elevated.
Numbers of CD3+ and CD4+ T-lymphocytes and myeloidperoxidase+ cells were increased whereas FoxP3+ T-cells were
detected at low frequency. This increased proinflammatory state was associated with ileal mucosal barrier loss as
demonstrated by decreased levels of the intestinal fatty acid binding protein and disruption of the tight junctional protein
ZO-1.
Conclusion: Intraamniotic IL-1a causes an acute detrimental inflammatory response in the ileum, suggesting that induction
of IL-1 is a critical element in the pathophysiological effects of endotoxin induced chorioamnionitis. A disturbed balance
between T-effector and FoxP3+ cells may contribute to this process.
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Introduction
Preterm delivery is the primary cause of neonatal morbidity and
mortality and its incidence worldwide is increasing [1]. The most
frequent association with preterm delivery is chorioamnionitis (a
histological inflammation of the fetal membranes) [2]. Prenatal
inflammation, commonly associated with chorioamnionitis and
prematurity, is linked with adverse outcomes of the gut including
poor nutritional uptake, subsequent postnatal growth restriction,
necrotizing enterocolitis and late onset sepsis [3–8]. However, the
mechanisms responsible for the association of antenatal inflam-
mation, preterm birth and the increased incidence of intestinal
disorders remain unknown.
Recently, we used a translationalmodel ofchorioamnionitisinfetal
sheep to evaluate the effects of antenatal inflammation on intrauterine
gut development. We showed that exposure of the preterm gut to
endotoxin disrupted maturation of the gut barrier and the innate
immune defence [9]. Intestinal inflammation induced by intraam-
niotic LPS was preceded by increased proinflammatory cytokines
with an inflammatory response in the chorioamnion and the lung
[10,11]. From the early proinflammatory cytokines that are known to
be produced after LPS induced chorioamnionitis, only intraamniotic
injection of IL-1 mimics the lung and systemic effects of LPS [12–14].
Therefore, we hypothesized that IL-1 mediated chorioamnionitis
would disrupt gut development.
We administered IL-1a by intraamniotic injection prior to
preterm delivery and evaluated the terminal ileum as the region of
the gastrointestinal tract most vulnerable to injury and intestinal
pathologies including NEC [15]. Fetal ileal inflammatory
responses were evaluated with immunohistochemistry to measure
myeloid peroxidase (MPO), CD3 and CD4 expressing cells and
the expression of FoxP3, a transcription factor required for the
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wall integrity was evaluated by the distribution of the tight
junctional protein Zonula Occludens-1 (ZO-1) which plays a
crucial role in paracellular barrier sealing. In addition, the amount
of intestinal Fatty Acid Binding Protein (I-FABP) was analyzed in
the gut as a marker for intestinal mucosal damage, since this small
cytosolic protein is present in mature enterocytes of small and
large intestines and released if the cell membrane integrity is
compromised [16,17].
Materials and Methods
Animals
The animal work for this study was performed in Western
Australia and approved by the Animal Ethics Committee of the
University of Western Australian and the Children’s Hospital
Medical Center, Cincinnati, OH (Approval ID 8D05048). Date
bred Merino ewes with singleton fetus were randomly assigned to
groups of six or seven animals to receive a single dose of 100 mg
Figure 1. Experimental design. Antenatal inflammation was induced
by a single injection of IL-1a under ultrasound guidance at 118, 122 or
124 d GA. Animals were delivered at 125 d GA and animals of the control
group underwent the same procedure with an injection of saline.
doi:10.1371/journal.pone.0018355.g001
Figure 2. Compared to control animals, a significant (*) increase of MPO immunoreactivity in the fetal terminal ileum was seen at
3 d and 7 d after IL-1a exposure. For each experimental group, mean cell counts of MPO positive cells are given per high-power field (A).
Representative sections of control animals and IL-1 treated animals for 3 d are depicted in B–C.
doi:10.1371/journal.pone.0018355.g002
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1 d, 3 d or 7 d before caesarian delivery at 125 d gestational age
(GA) (Figure 1). Control animals received intraamniotic injections
with saline under ultrasonic guidance at the same timepoints
(Figure 1). The 125 d GA of the fetal lambs is comparable with a
human GA of approximately 27 weeks.
The biological activity of IL-1a was previously described in this
model [10]. We recently described the pathological evidence of
chorioamnionitis following intraamniotic IL-1 injection in this
ovine model [18]. Briefly, 1–2 d following intra-amniotic injection
of IL-1 alpha, inflammation in the chorioamnion was shown by
histology and increased cytokine levels. In addition, increased
recruitment of inflammatory cells and enhanced cytokine levels
were detected in the amniotic fluid.
Antibodies
The following antibodies were used: rabbit antibodies against
human MPO and CD3 (Dakocytomation, Glostrup, Denmark), I-
FABP (Hycultbiotech, Uden, the Netherlands) and Zonula
Occludens protein 1 (ZO-1) (Invitrogen, San Francisco, CA);
monoclonal antibodies against bovine CD4 (VMRD, Pullman,
WA), human FoxP3 (eBioscience, San Diego, CA) and beta-actin
(Sigma, Chicago, IL). Secondary antibodies, biotin conjugated
rabbit anti-mouse or swine anti-rabbit and Texas red conjugated
goat anti-rabbit were purchased from Dakocytomation and
peroxidase conjugated goat anti-rabbit from Jackson (West Grove,
PA). The specificity of all antibodies used in this study was
extensively tested including the different secondary antibodies in
combination with the appropriate isotype matched controls.
Immunohistochemistry
Terminal ileal tissue was immersed in 10% buffered formalin
for 24 h at 4uC. The formalin fixed samples were embedded in
paraffin and 3 mm sections were cut. For detection of CD3
expressing cells, slides were boiled in 10 mM Na-citrate (pH 6.0)
for 20 min. Endogenous peroxidase activity was blocked with
0.3% H2O2 in methanol. Slides were blocked with either normal
goat serum (MPO, FoxP3) or bovine serum albumin (CD3, CD4)
for 30 min at room temperature. Slides were incubated with the
primary antibody of interest for 1 h at room temperature (CD3,
Figure 3. At 3 d and 7 d after intraamniotic IL-1a injection, significant increases of CD3 positive cells in the fetal terminal ileum
were detected when compared with saline treated animals. For each experimental group, mean cell counts of CD3 expressing cells per high-
power field are depicted (A). Representative sections of saline and 3 d IL1a treated animals are shown (B–C).
doi:10.1371/journal.pone.0018355.g003
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sections were incubated with the appropriate secondary conjugat-
ed antibody. CD3 and FoxP3 antibodies were detected with the
streptavidin-biotin system (Dakocytomation) and antibodies
against MPO and CD4 were detected using a peroxidase
conjugated secondary antibody. Positive staining for MPO, CD3
and CD4 was visualized with 3-amino-9-ethylcarbazole (AEC,
Sigma); nuclei were counterstained with haematoxylin. Immuno-
reactivity for FoxP3 was visualized using nickel-DAB. The
numbers of cells exhibiting immunostaining were counted as
follows: for MPO, CD3 and CD4, the average number of 3
different high power fields at a 2006magnification were given; for
FoxP3, the sum of three high power fields (1006) was estimated.
The immunohistochemical analysis was scored by 3 investigators
who were blinded to the experimental conditions.
Immunofluoresence
Immunofluoresence was performed and interpreted as de-
scribed earlier [9]. Briefly, frozen ileal sections (3 mm) were
incubated with anti-ZO-1 and Texas Red conjugated goat anti
rabbit antibody (Jackson, West Grove, PA) respectively, followed
by a 2 min incubation with 49,6-diamino-2-phenyl indole (DAPI).
The distribution of ZO-1 was recorded at a magnification of 2006
using the Metasystems Image Pro System (black and white charge-
couple device camera; Metasystems, Sandhausen, Germany)
mounted on a Leica DM-RE fluorescence microscope (Leica,
Wetzler, Germany).
Cytokine mRNA Quantitation
Total RNA was isolated from terminal ileal tissue by Trizol/
chloroform extraction. mRNA quantitation was performed using
real-time PCR. Total RNA was reverse transcribed using oligo(dT)
primer and Moloney murine leukemia virus reverse transcriptase
(Life Technologies) according to the supplier’s recommendations.
cDNA was used as a template with primers and Taqman probes
(Applied Biosystems, Carlsbad CA) specific to sheep sequences. The
values for each cytokine were normalized to the internal 18S rRNA
value. Data were expressed as fold increase over the control value.
Figure 4. At 3 d and 7 d after intraamniotic IL-1a injection, the number of CD4 positive cells significantly increased when compared
with saline treated animals. A) For each experimental group, mean cell counts of CD4 expressing cells are expressed per high-power field. B–C)
Representative sections of saline and 3 d IL-1a treated animals are shown.
doi:10.1371/journal.pone.0018355.g004
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Protein sample Intestinal tissue samples were homogenized in
lysis buffer (200 mM NaCl, 10 mM Tris base, 5 mM EDTA,
10% Glycerin, 1 mM PMSF, 0.1 U/mL Aprotinin and 1 mg/
mL Leupeptin). Homogenates were centrifuged at 300 rpm for
10 min; supernatants were collected and centrifuged again at
10 000 rpm for 3 min. Total protein concentrations in the final
supernatants were determined using the bicinchoninic acid
(BCA) protein assay (Pierce Rockford, IL). To confirm equal
protein loading, immunoblotting was performed with an anti-b-
actin antibody. Aliquots with equal amounts of protein were
heated at 100uC for 5 min in SDS sample buffer, separated on
15% SDS–polyacrylamide gels and transferred to nitrocellulose
(Schleicher&Schull, Dassel, Germany). After blocking, mem-
branes were probed with the indicated antibodies, followed by
an IRDye700-conjugated secondary antibody of the appropriate
species (LI-COR, Lincoln, NE, USA). Protein bands were
visualized using an Odyssey Infrared Imaging System (LI-
COR).
Statistical analysis
The number of cells exhibiting immunostaining for MPO, CD3
and FoxP3 were counted per high power field. Mann-Whitney U-
tests were used for between-group comparisons. Statistical calcula-
tions were made using SPSS 15.0 for Windows (SPSS, Chicago, IL)
and differences were considered statistically significant at p,0.05.
Results
Inflammation in the fetal ileum
In preterm control animals, a small number of cells expressing
MPO were detected. There was a variable increase in the number
of infiltrating MPO positive cells after 1 d exposure to IL-1a
(Figure 2A). However, the number of MPO+ cells was significantly
increased in animals exposed to IL-1a for 3 d and 7 d when
compared to control animals (Figure 2A). Representative sections
of the control and 3 d groups are shown in Figure 2B–C.
The influx of CD3+ and CD4+ T-cells into the fetal ileum
largely paralleled the influx of MPO+ cells. In preterm lambs
Figure 5. A single intraamniotic injection of IL-1a significantly reduced the number of FoxP3 expressing cells. A) Mean cell counts of
FoxP3+ positive cells were measured for the sum of 3 high-power fields. Representative ileal sections of saline (B) and 3 d IL1a (C) treated animals are
shown. For inset, 4006magnification was used.
doi:10.1371/journal.pone.0018355.g005
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expressing T-cells in the lamina propria was observed when
compared with control tissue whereas increased numbers of CD3
and CD4 expressing cells were identified at 3 d and 7 d post IL-1a
treatment (Figure 3A and Figure 4A). Representative CD3 and
CD4 stained ileal sections for the control and 3 d post IL-1a
groups are shown in Figures 3B–C and Figure 4B–C respectively.
Next, we identified the distribution of cells expressing the
transcription factor FoxP3, the most commonly used marker for
T-reg identification. When compared to control animals, FoxP3
positive cells decreased at 1 d, 3 d and 7 d after IL-1a exposure
with the lowest numbers in the 3 d group (Figure 5A). Represen-
tative ileal sections for the control and 3 d post IL-1a groups are
shown in Figures 5B–C.
Intraamniotic injection of IL-1a strongly induced the mRNA
expression of TNF-a, IFN-c, IL-4 and IL-10 whereas IL-17 was
only moderately induced 3 d post IL-1 treatment (Figure 6).
Ileal barrier
Next, we asked whether the barrier integrity of the ileum was
altered by IL-1a. To this end, we first analyzed intestinal levels of
I-FABP, a small protein present in the cytoplasm of differentiated
enterocytes. Compared to controls, intestinal I-FABP levels
decreased within 1 d after IL-1a exposure reaching statistical
significance at 3 and 7 d post IL-1a exposure (Figure 7).
We also stained for the tight junctional protein ZO-1, a
225 kDa membrane bound protein which binds the transmem-
brane tight junction proteins occludin and claudins and links them
to cytoskeletal actin [19]. ZO-1 localization was disturbed in
premature control animals (Figure 8A) and this localization
pattern was not changed after 1 d of IL-1a exposure (not shown).
Fetuses exposed to IL-1a for 3 d (Figure 8B) and 7 d (Figure 8C)
had more fragmented ZO-1 when compared with control animals.
Discussion
We recently showed that endotoxin induced chorioamnionitis
provoked an inflammatory response in the preterm ileum that
interfered with maturation of the fetal intestinal immune system
and ileal barrier function [9].
In the present study, we demonstrate that these harmful effects
of intraamniotic endotoxin can be largely recapitulated by
intraamniotic IL-1a, as indicated by the strong increase of
inflammatory cytokines and concomitant barrier loss following
IA IL-1a delivery. However, the influx of lymphocytes after
intraamniotic LPS injection was more robust when compared to
the effects of intraamniotic IL-1 injection. Therefore, this study
demonstrates that induction of IL-1 is an important but not the
only pathway, involved in fetal ileal inflammation and concom-
itant ileal barrier loss in the course of chorioamnionitis.
These results may have clinical relevance since IL-1a and IL-1b
increase in the amniotic fluid during clinical chorioamnionitis and
in patients with premature rupture of membranes [20–23].
Moreover, loss of the ileal barrier in utero such as seen in our
translational model following IL-1 driven intestinal inflammation
might explain the association between chorioamnionitis and the
increased risk for adverse outcomes of the gut, since gut barrier
loss is not only associated with poor nutrition and subsequent
postnatal growth restriction, but also contributes to intestinal
pathologies after preterm birth including necrotizing enterocolitis
[24].
The harmful pro-inflammatory status of the ileum after
intraamniotic IL-1a delivery could result from the decrease of
FoxP3+ cells. This transcription factor is essential for the function
of T-reg cells, which suppress T-effector cells. Although FoxP3 is
the most commonly used marker for T-reg cells, its expression is
upregulated in recently activated non T-reg cells in humans [25–
27]. Therefore, we cannot rule out the possibility that FoxP3 is
present in non-regulatory T-cells in our ovine model. However,
since FoxP3 is decreased concomitant with the increased T-cell
activation markers, this latter option seems less likely.
FoxP3+ cells decreased within 24 h after IL-1 exposure and this
occurred prior to the increased influx of MPO+ cells and effector
T-cells. It is tempting to speculate that loss of the inhibitory
functions of T-reg cells on effector T-cells disturbs intestinal
lymphoid and mucosal homeostasis, resulting in excessive immune
activation and tissue damage. Alternatively, the early loss of T-reg
could result in uncontrolled dendritic cell activation, which would
lead to effector T-cell influx and activation. Whatever the exact
target of T-reg is, such a mechanism would be consistent with
earlier animal experiments and findings in humans which
demonstrate that T-reg cells are critical for maintenance of
intestinal tolerance to luminal antigens and for prevention of
intestinal inflammation [28–30].
The observed depletion of FoxP3+ cells, presumed to be T-regs
in fetal sheep, could be mediated by different mechanisms. These
reduced numbers could be caused by increased death or
decreased proliferation of regulatory T-cells [31]. On the other
hand, T-reg cells could lose Foxp3 expression under inflamma-
tory conditions. For instance, IL-4 can inhibit the generation of
T-reg cells [32,33]. Since depletion of T-reg preceded induction
of IL-4 mRNA levels, one might argue that IL-4 is not
responsible for this initial loss of Foxp3 expressing cells, rather
it could be involved in maintenance of low T-reg numbers.
Alternatively, IL-6 has been reported to induce conversion of T-
reg cells to Th17 cells, thereby downregulating the expression of
FoxP3 [34,35]. However, this latter option does not seem likely
since IL-17 mRNA levels are only marginally increased after
intraamniotic IL-1 delivery. Another possibility is that impaired
Figure 6. Quantification using real-time PCR assays using sheep specific primers and Taqman probes. The values for each cytokine were
normalized to 18s rRNA. The mean mRNA signal in control animals was given the value of 1 and levels at each time point were expressed relative to
controls (*p,0.05 vs control).
doi:10.1371/journal.pone.0018355.g006
Figure 7. The I-FABP content in the terminal ileum is reduced
within 1 d after IL-1a treatment and I-FABP levels remain low
up to 7 d after intraamniotic IL-1a administration. A) Represen-
tative b-actin and I-FABP protein fragments are shown for each group.
B-actin was used to confirm equal loading. Relative quantitative data
were obtained by densitometric evaluation of actin and I-FABP
products which were compared to a standard curve obtained by
amplification of a serial dilution of a highly concentrated protein
standard (*p,0.05 vs control).
doi:10.1371/journal.pone.0018355.g007
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observed loss of T-reg cells, since this signaling pathway was
recently been shown to be required for regulation and induction
of T-reg cells in the gut [36].
To our knowledge, this is the first report of (regulatory) T-cells
in the preterm fetal ileum. Moreover, postnatal findings are
limited. Weitkamp et al. provided data concerning postnatal
developmental regulation of T-reg cells in relationship to other T
cells in intestinal samples of preterm infants with and without NEC
[37]. In line with our in utero findings, T-regs decreased during
intestinal inflammation, but in contrast with our data, T-effector
cells were decreased in the inflamed gut when compared to the
healthy premature intestine [37]. This discrepancy could have
multiple explanations such as the exposure of the gut to an antigen
load following birth. Our model is unique as a single agonist is
inducing the multiple responses in a naı ¨ve preterm fetal gut.
Interestingly, concomitant with the influx of MPO+ cells and
CD3+/CD4+ effector cells, a strong induction of IL-10 was
observed. Although this cytokine is critical for preservation of gut
integrity as shown in IL-10 deficient mice [38], our results suggest
that maintenance of FoxP3+ cells may be more critical than IL-10
induction.
Taken together, the important conclusion from the present
study is that IL-1 signaling in the amniotic compartment can
recapitulate pathogenesis of chorioamnionitis-induced inflamma-
tion of the ileum, and potentially its adverse outcomes.
Furthermore, suggestive evidence is provided that a disturbed
balance between effector T-cells and FoxP3+ cells plays a role in
ileal inflammation and subsequent mucosal damage in utero
following chorioamnionitis.
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